EN
HI

Concord Drugs Share price

CONCORD

55.84

1.09 (1.99%)
Last updated on 7 Aug, 2025 | 15:15 IST
BUYSELL
Today's High

55.84

Today's Low

53.66

52 Week Low

26.10

52 Week High

67.00

The current prices are delayed, login to your account for live prices

Concord Drugs Chart

Concord Drugs Share Key Metrics

Volume
8062.00
Market Cap
54.75 CR
LTQ@LTP
5000@55.84
ATP
55.32
Var Margin
100 %
Circuit Range
53.66-55.84
Delivery %
0 %
Value
4.46 L
ASM/GSM
No
Market Lot
1

Concord Drugs Futures & Options

Data Not Found

Concord Drugs Corporate Actions

DateAgenda
2025-08-08Quarterly Results
2025-07-03Preferential issue of shares
2025-06-27Preferential Issue of shares & Others
2025-05-23Audited Results
2025-03-17Preferential Issue of shares & Others
2025-03-13Preferential Issue of shares & Others
DateRecord Date
No Data Found

Concord Drugs News

BRIEF-Concord Drugs Says Approved Sale Of Non-Agricultural/Industrial Land, Ground, With Structures In Uttarakhand State

Oct 13 2020 19:21:03
Read More

About Concord Drugs

NSE : 0  
BSE : 538965  
ISIN : INE858L01010  

CONCORD DRUGS LIMITED a company with its registered office at 5-9-22/36 Adarsha Nagar Hyderabad - 500463 (With effect from 14196 as for resolution dated 1.4.96 Change of Registered Office is being file with ROC was incorporated as a public limited company on 24th April 1995. The factory of the company is situated at survey No.s 248-251 Torruru Village Brahmanapally post Hyathnagar mandal R.R.Dist. Andhra Pradesh. The main objects of the company is to carry on the business of manufacturing and selling of pharmaceuticals formulations i.e. Tablets Capsules Liquids and Sterile Powder Injections Bio Adhesive and Radio Opec agent.SUBSIDIARIES OF THE COMPANYThe company has no subsidiary.

Concord Drugs Management

NamePosition
Mr. S Nagi Reddy Chairman & Managing Director
Mr. S Manoj Kumar Reddy Whole Time Director
Mr. S Koni Reddy WholeTime Director & CFO
Mr. K Ramachandra Reddy Independent Director
Ms. Sumeela Kasu Independent Director
Read More

Concord Drugs FAQs

The Buying Price of Concord Drugs share is 55.84 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Concord Drugs shares is 162.95. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Concord Drugs shares is 1.6. Useful to assess the stock's value relative to its book value.

To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 34.45 & 3.67 with sector averages, along with growth rates and financial metrics.

The Market Cap of Concord Drugs is 54.75 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Concord Drugs share price is 67.00 & 26.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.